RYLEE WAINWRIGHT: Open Payments
NPI 1821733460 · STARKE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 14 payments from 8 companies in 2025. Trend: 2023 $156 · 2024 $314 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Amgen Inc. | 3 | $52 |
| CeQur Corporation | 1 | $40 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: OTEZLA, CeQur Simplicity, QULIPTA, MOUNJARO, UBRELVY, PREVNAR 20, CAPLYTA, Ozempic.
Industry payments across FL — which companies pay providers there.
